|
CHD8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.52729999991897E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.476100E-03 |
| Normal-vs-Stage2 |
1.85330000002093E-06 |
| Normal-vs-Stage3 |
1.57699964198343E-10 |
| Normal-vs-Stage4 |
1.42590000029585E-07 |
| Stage1-vs-Stage2 |
9.844500E-03 |
| Stage1-vs-Stage3 |
2.48619999998478E-06 |
| Stage1-vs-Stage4 |
6.780000E-04 |
| Stage2-vs-Stage3 |
5.753600E-01 |
| Stage2-vs-Stage4 |
7.301800E-01 |
| Stage3-vs-Stage4 |
8.779000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.75929999959956E-07 |
| Normal-vs-AfricanAmerican |
4.636400E-03 |
| Normal-vs-Asian |
7.851600E-01 |
| Caucasian-vs-AfricanAmerican |
3.994200E-01 |
| Caucasian-vs-Asian |
1.254380E-01 |
| AfricanAmerican-vs-Asian |
3.076800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.83110000285103E-08 |
| Normal-vs-Female |
4.641400E-04 |
| Male-vs-Female |
1.944280E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.824500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.820400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.76439999780109E-08 |
| Normal-vs-Age(81-100Yrs) |
3.65050000000755E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.285200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.602000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.152600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.533800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.727800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.990810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.326590E-01 |
| Normal-vs-Grade 2 |
8.766600E-04 |
| Normal-vs-Grade 3 |
4.11250000720287E-09 |
| Normal-vs-Grade 4 |
1.85120000439909E-08 |
| Grade 1-vs-Grade 2 |
2.602800E-03 |
| Grade 1-vs-Grade 3 |
1.53544000000005E-05 |
| Grade 1-vs-Grade 4 |
4.4728000000438E-06 |
| Grade 2-vs-Grade 3 |
1.559920E-03 |
| Grade 2-vs-Grade 4 |
1.136210E-03 |
| Grade 3-vs-Grade 4 |
2.700800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.359390E-03 |
| Normal-vs-ccB subtype |
1.23520000006039E-07 |
| ccA subtype-vs-ccB subtype |
1.957030E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.53299999997125E-06 |
| Normal-vs-N1 |
1.811830E-04 |
| N0-vs-N1 |
1.643810E-01 |
|
|
